Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D K Scott

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Postgraduate Medical Journal|September 1, 1989
Control of warfarin therapyD K Scott
The Journal of Antimicrobial Chemotherapy|November 1, 1988
Optimal blood sampling time for gentamicinC Edwards, D K Scott
British Journal of Pharmacology|July 1, 1979
Geometry of guinidine-like antiarrhythmic drugs [proceedings]C H Schwalbe, D K Scott
British Journal of Clinical Pharmacology|March 1, 1994
'The strategy of desire' and rational prescribingD K Scott, R E Ferner
BMJ (Clinical Research Ed.)|December 24, 1994
Whatalotwegot--the messages in drug advertisementsR E Ferner, D K Scott
Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibagsM J Wood, W J Irwin, D K Scott
Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatographyM J Wood, W J Irwin, D K Scott
The Biochemical Journal|September 1, 1995
Retinoid receptors cause distortion of the retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoterD K Scott, R K Hall, D K Granner
The Journal of Biological Chemistry|December 13, 1996
The orphan receptor COUP-TF binds to a third glucocorticoid accessory factor element within the phosphoenolpyruvate carboxykinase gene promoterD K Scott, J A Mitchell, D K Granner
The Journal of Biological Chemistry|March 15, 1996
Identification and charaterization of the second retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoterD K Scott, J A Mitchell, D K Granner
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Postgraduate Medical Journal|September 1, 1989
Control of warfarin therapyD K Scott
The Journal of Antimicrobial Chemotherapy|November 1, 1988
Optimal blood sampling time for gentamicinC Edwards, D K Scott
British Journal of Pharmacology|July 1, 1979
Geometry of guinidine-like antiarrhythmic drugs [proceedings]C H Schwalbe, D K Scott
British Journal of Clinical Pharmacology|March 1, 1994
'The strategy of desire' and rational prescribingD K Scott, R E Ferner
BMJ (Clinical Research Ed.)|December 24, 1994
Whatalotwegot--the messages in drug advertisementsR E Ferner, D K Scott
Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibagsM J Wood, W J Irwin, D K Scott
Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatographyM J Wood, W J Irwin, D K Scott
The Biochemical Journal|September 1, 1995
Retinoid receptors cause distortion of the retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoterD K Scott, R K Hall, D K Granner
The Journal of Biological Chemistry|December 13, 1996
The orphan receptor COUP-TF binds to a third glucocorticoid accessory factor element within the phosphoenolpyruvate carboxykinase gene promoterD K Scott, J A Mitchell, D K Granner
The Journal of Biological Chemistry|March 15, 1996
Identification and charaterization of the second retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoterD K Scott, J A Mitchell, D K Granner
Pageof 4